Lineage Cell Therapeutics (LCTX) Convertible Debt (2014 - 2017)
Lineage Cell Therapeutics (LCTX) posted quarterly Convertible Debt of $1.9 million for Q4 2017, up 80.72% year-over-year from $1.0 million in Q4 2016, and up 73.17% quarter-over-quarter from $1.1 million in Q1 2017.
Lineage Cell Therapeutics (LCTX) Convertible Debt (2014 - 2017) Analysis & Trends
Lineage Cell Therapeutics' Convertible Debt history runs 4 years deep, the most recent figure standing at $1.9 million for Q4 2017.
- In Q4 2017, Convertible Debt rose 80.72% year-over-year to $1.9 million; the TTM figure through Dec 2017 stood at $1.9 million (up 80.72% YoY), while the FY2017 annual figure was $1.9 million, up 80.72% from the prior year.
- Convertible Debt for Q4 2017 stood at $1.9 million, up from $1.1 million in the prior quarter.
- The five-year high for Convertible Debt was $1.9 million in Q4 2017, with the low at $60000.0 in Q4 2014.
- The 4-year median for Convertible Debt is $617908.0 (2015), against an average of $741132.4.
- The sharpest annual moves came in 2015 and 2016: Convertible Debt soared 440.0% in 2015, then slipped 26.33% in 2016.
- Lineage Cell Therapeutics' Convertible Debt stood at $60000.0 in 2014, then jumped by 440.0% to $324000.0 in 2015, then jumped by 218.52% to $1.0 million in 2016, then surged by 80.72% to $1.9 million in 2017.
- Business Quant data shows LCTX's Convertible Debt at $1.9 million in Q4 2017, $1.1 million in Q1 2017, and $1.0 million in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Lineage Cell Therapeutics | 270.61 Mn | 212.77 Mn | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 1.87 Mn |
| Mar 31, 2017 | 1.08 Mn |
| Dec 31, 2016 | 1.03 Mn |
| Sep 30, 2016 | 954,000.00 |
| Jun 30, 2016 | 701,000.00 |
| Mar 31, 2016 | 394,000.00 |
| Dec 31, 2015 | 324,000.00 |
| Mar 31, 2015 | 534,816.00 |
| Dec 31, 2014 | 60,000.00 |
| Sep 30, 2014 | 469,508.00 |